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Purpose: Imaging features and clinical characteristics of degenerated leiomyoma 
in patients referred for uterine fibroid embolization (UFE) were analyzed to assess 
the incidence of degenerated leiomyoma. Materials and Methods: Patients re-
ferred for UFE between 2008 and 2009 were retrospectively analyzed (n=276). 
Patients ranged in age from 27 to 51 years (mean 38.0 years). All patients under-
went screening MRI with contrast enhancement. Medical histories and clinical 
symptoms were evaluated. Results: Among the 276 patients who underwent MRI, 
14 (5.1%) showed degenerated leiomyomas. Symptoms were abdominal pain 
(n=4, 26.7%), menorrhagia (n=5, 35.7%) and bulk-related symptoms (n=5, 
35.7%) and no symptoms (n=5, 35.7%). Of the 14 patients with degenerated leio-
myomas, 5 (42.9%) had a history of pregnancy in the past two years. For T1-
weighted imaging (T1WI), a high signal intensity (SI) of the leiomyoma was the 
most common finding (n=9, 64.3%) and a hyperintense rim (n=4, 28.6%) was the 
second most common. On T2-weighted imaging (T2WI), a low SI of the leiomyo-
ma was found in six patients (42.9%), a high SI in four (28.6%) and a heteroge-
neous SI in four (28.6%) patients. Conservative management was performed in 11 
(78.6%) patients, surgery in 3 (21.4%) and uterine artery embolization in one 
(7.1%) patient. Conclusion: The incidence of degeneration of leiomyoma in pa-
tients referred for UFE was 5.1%. Patients presented with variable clinical symp-
toms with or without a history of pregnancy. MR imaging showed a high SI on 
T1WI and various SIs on T2WI without contrast enhancement. An understanding 
of the degeneration of leiomyomata is essential when considering UFE.
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INTRODUCTION
Uterine leiomyomas, the most common solid tumor of the female genital tract, de-
velops in 20-40% of women during their reproductive years.1 Degeneration of leio-
myoma occurs secondary to a loss of blood supply and is usually attributable to rap-
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HD/HDx; GE Healthcare, Waukesha, WI, USA) of the pel-
vis. Axial and sagittal fast spin echo T2-weighted imaging 
(T2WI; TR/effective TE, 4400/120; matrix size, 384×224; 
field of view, 300×300 mm; section thickness, 5 mm) and 
contrast-enhanced sagittal T1-weighted imaging (T1WI) 
were performed in all cases. An enhanced MRI (TR/TE, 
766/9; flip angle 90°; matrix size, 256×160; field of view, 
300×300 mm; section thickness, 5 mm) was performed 2 
min after intravenous infusion of the 10 mL gadolinium 
contrast agent (Dotarem, Guerbet, Villapente, France). De-
generated leiomyoma was defined as a leiomyoma showing 
inhomogenous signal intensity (SI) on T2WI with irregular, 
peripheral, minimal or absent enhancement compared with 
that of myometrium.8
SI was defined as either high, greater than the SI of the 
normal myometrium; intermediate, equal to the SI of the nor-
mal myometrium; or low, less than the SI of the normal myo-
metrium. Imaging features of the degenerated leiomyoma 
were analyzed. 
Assessment of clinical symptoms
We evaluated patient information related to medical history 
and clinical symptoms and signs.
Menorrhagia, dysmenorrhea and bulk-related symptoms 
such as urinary frequency or sensations of pelvic heaviness, 
were analyzed. In one patient who needed uterine artery 
embolization, a coaxial 3-F microcatheter (MicroFerret; 
Cook, Bloomington, IN, USA) was advanced distally into 
the uterine artery through the right femoral artery and em-
bolization was performed with 250-355 and 355-500 µm 
id growth associated with pregnancy. It can cause severe pain 
not relieved by sedation as well as fever or leukocytosis. De-
generation of a leiomyoma is treated pain medication or sur-
gical intervention. Uterine fibroid embolization (UFE) was 
established as an alternative to a hysterectomy for the treat-
ment of symptomatic leiomyomas.2-5 However, patients with 
degenerated leiomyoma are more likely to have a poor re-
sponse to UFE, and it is often difficult to differentiate symp-
toms and ultrasonographic findings in patients with degener-
ated leiomyoma from those in patients with non-degenerated 
leiomyomas.6,7 Therefore, being aware of any existing de-
generated leiomyoma before performing UFE is mandatory. 
The aim of this study was to assess the incidence, imaging 
features and clinical characteristics of degenerated leiomyo-
ma in patients who were referred for UFE. 
MATERIALS AND METHODS
　　　
The Institutional Review Board at Severance Hospital of 
Yonsei University approved this study. A retrospective anal-
ysis of 276 patients referred for UFE between 2008 and 
2009 was performed. All patients underwent transvaginal 
or transabdominal ultrasound and uterine leiomyomas were 
primarily diagnosed by gynecologists. Patients ranged in 
age from 27 to 51 years (mean 38.0 years). The mean fol-
low-up period was 9.7 months (range: 5-16 months). 
MRI 
All patients underwent a preoperative MRI (1.5-T Signa 
Table 1. Clinical Characteristics of the Patients (n=14)
Case     Age
Diameter (cm) of 
the leiomyoma  
Recent history of 
pregnancy    
Symptoms Treatment
  1 32   6.1 Yes (abortion) aSx Observation 
  2 24   6.9 No Abdominal pain, menorrhagia Conservative 
  3 31   8.3 Yes (delivery) aSx Observation 
  4 31 10 Yes (delivery) aSx Observation 
  5 34 15.5 Yes (delivery) Pelvic heaviness, palpable mass Myomectomy
  6 28   6.7 No Pelvic heaviness, urinary frequency Observation
  7 26   6.2 No aSx Observation 
  8 31   5.2 No Abdominal pain Myomectomy due to pain
  9 41 10 No Abdominal pain, pelvic heaviness Hysterectomy
10 37   7.1 Yes (delivery) Menorrhagia Observation 
11 45   8.5 No Menorrhagia (combined adenomyosis) Uterine artery embolization
12 34   7.1 No Menorrhagia, pelvic heaviness Observation 
13 34   5.2 No aSx Observation 
14 37   6 Yes (abortion) Menorrhagia, pain, pelvic heaviness Conservative
aSx, asymptomatic. 
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from 7.3 cm to 6.7 cm at follow-up. Four (80.0%) out of the 
five patients showed a decrease in the leiomyoma size (Fig. 
1), while no significant interval change in the size of the 
uterine leiomyoma was noted in the remaining patient. 
Symptoms, history of pregnancy and treatment 
Symptoms noted were abdominal pain (n=4, 26.7%) in-
cluding acute onset of pain (n=2), menorrhagia (n=5, 
35.7%) and bulk-related symptoms (n=5, 35.7%) such as 
pelvic heaviness and palpable mass. Five (35.7%) patients 
had no symptoms. Of the 14 patients with leiomyomas, five 
(42.9%) had a history of pregnancy in the past two years. 
Observation with or without conservative management was 
performed in 10 (71.4%) patients, surgery in three (21.4%) 
and uterine artery embolization in one (7.1%) patient. Of the 
three patients who had surgery, two underwent myomecto-
my and one had a hysterectomy. Those patients had either 
bulk-related symptoms (n=2) due to a huge leiomyoma, or 
pain (n=1) for more than a week that was not relieved by an-
algesics. One patient underwent uterine artery embolization 
due to heavy bleeding, and the MRI revealed combined ad-
enomyosis as well as the degenerated leiomyoma. For that 
patient, the three-month follow-up MRI after embolization 
revealed complete necrosis of the adenomyosis but little in-
size of non-spherical polyvinyl alcohol particles (Contour; 
Boston Scientific, Natick, MA, USA). 
Clinical follow-up
Follow-up using ultrasound or MRI was performed and the 
size of the leiomyoma was assessed. In one patient who un-
derwent uterine artery embolization, MRI was performed 




Demographics and clinical characteristics of the patients of 
the patients are summarized in Table 1. 
Among 276 patients who with MRI data, 14 (5.1%) showed 
degenerated leiomyomas. The size of the degenerated leio-
myomas ranged from 5.2 cm to 15.5 cm (mean 7.7 cm). 
Nine patients had leiomyomas less than 8 cm in size while 
only three patients had leiomyomas larger than 10 cm. 
Imaging features
MR imaging features of the degenerated leiomyomas from 
all 14 patients are summarized in Table 2. Completely degen-
erated leiomyomas without any contrast enhancement were 
noted in 11 patients while a partial viable rim of the degener-
ated leiomyomas was seen in three patients. On T1WI, a 
high SI of the leiomyoma was the most common finding 
(n=9, 64.3%) and a hyperintense rim (n=4, 28.6%) was the 
second most common. On T2WI, a low SI of the leiomyoma 
was found in six patients (42.9%), a high SI in four (28.6%) 
including a hypointense rim in three of those patients. A het-
erogeneous SI was found in four (28.6%) patients. A follow-
up study was performed in five patients by MRI (n=1) or 
US (n=4). The mean diameter of the leiomyoma decreased 
Table 2. MR Imaging Features of Degenerated Leiomyomas 
(n=14)
T1WI T2WI        
Low 6
Intermediate 1





Fig. 1. A 31-year-old woman who had a normal spontaneous vaginal delivery one year prior. (A) The T1-weighted axial image revealed a 7.0×8.3×6.7 cm leio-
myoma (arrows) on the posterior wall of the uterus showing high signal intensity. (B) The T2-weighted sagittal image revealed a heterogenous signal inten-
sity of the leiomyoma. (C) Contrast enhancement was not observed on the gadolinium-enhanced T1-weighted axial image corresponding to B. (D) The fol-
low-up MRI at 18 months demonstrated a 7.4×5.7×6.5 cm leiomyoma, which represents a 29.7% decrease (143 cc from 204 cc) in leiomyoma volume without 
any treatment.
A B C D
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data were abdominal pain including acute onset of pain, 
menorrhagia, and bulk-related symptoms. These symptoms 
are similar to those of non-degenerated leiomyomas except 
acute onset of abdominal pain, which is unusual. A degener-
ating uterine leiomyoma is often misdiagnosed, frequently 
being confused with subacute salpingo-oophoritis. A pe-
dunculated subserosal leiomyoma can undergo torsion 
ischemic necrosis, which is associated with pain similar to 
that of adnexal torsion. 
Degenerating leiomyoma have various nonspecific MRI 
appearances ranging from medium to high SI on T1WI to a 
heterogeneous, mostly high SI in the area of degeneration 
on T2WI.9,12,13 Kawakami, et al.11 reported that red degener-
ation of uterine leiomyoma had a hyperintense rim on T1WI 
and a hypointense rim on T2WI. Microscopic examination 
revealed numerous dilated thrombosed vessels filled with 
red blood cells at the periphery and these red blood cells in 
the thrombosed vessels have abundant levels of intracellu-
lar methemoglobin, which is known to appear as a hyperin-
tense signal on T1WI and a hypointense signal on T2WI. 
The incidence of degeneration of leiomyoma in patients 
referred for UFE in our study was 5.1%, with the majority 
of them having undergone conservative treatment. Most pa-
tients were initially recommended to undergo surgery after 
consultation with gynecologists, but these patients wanted a 
minimally invasive surgery to preserve their uteri. Rest and 
sedation are recommended in most cases. The pain of red 
degeneration usually resolves within ten days and support-
ive treatment is required for this period only. Follow-up ul-
trasounds or MRIs in our data demonstrated spontaneous 
reductions in size of the leiomyoma with concurrent im-
provement of symptoms. Meanwhile, surgery may be need-
ed in some patients with intractable pain. One patient in our 
study elected to undergo myomectomy for severe pain not 
controlled with medication, which lasted more than one 
week. Degenerated leiomyomas are known for their contra-
indication for UFE due to the likely poor response, as they 
may already have undergone hemorrhagic necrosis. How-
ever, a patient in our study underwent uterine artery embo-
lization for bleeding because of concurrent adenomyosis. 
The patient’s symptoms were significantly improved after 
embolization, but the volume of the degenerated leiomyo-
ma demonstrated little change. 
A limitation of the present study was the relatively small 
number of patients; therefore, and further studies are need-
ed with larger study populations. 
In summary, the incidence of degeneration of leiomyoma 
terval change in the volume of the degenerated leiomyoma. 
Symptoms in one patient who had menorrhagia had sponta-
neously resolved at the six-month follow-up.
DISCUSSION
The process of leiomyoma degeneration usually begins 
when the leiomyoma grows so large that the nearby blood 
vessels can no longer supply it with oxygen and nutrients. 
Degeneration of the leiomyoma results in a variable and of-
ten heterogeneous appearance, with minimal or irregular 
enhancement. Degeneration is categorized as hyaline, cys-
tic, red or calcific. The most common type of degeneration 
is hyaline; it accounts for approximately 60% of all degen-
eration and produces a low SI on T2WI, without contrast 
enhancement.9,10 Cystic degeneration occurs in approxi-
mately 4% of leiomyomas and typically occurs after hya-
line degeneration.10 
Red degeneration is a hemorrhagic infarction of the uter-
ine leiomyoma, which is a well known complication, espe-
cially during pregnancy. Red degeneration occurs in 8% of 
tumors complicating pregnancy, although the prevalence is 
about 3% of all uterine leiomyoma.11 Our data indicated 
that about 42.9% of patients had been pregnant in the previ-
ous two years. The mechanism of red degeneration is sug-
gested to begin with venous obstruction at the periphery of 
the lesion, which induces hemorrhagic infarction and ex-
tensive necrosis that involves the entire lesion. 
As leiomyoma enlarge, they may outgrow their blood 
supply, resulting in degeneration, thus degeneration occurs 
primarily in large leiomyomas. However, our study demon-
strated that the majority of patients in whom degeneration 
was found had leiomyomas less than 8 cm in size; it was 
even detected in leiomyomas as small as 5.2 cm. One pos-
sible explanation seems to come from the widespread use 
of MRI, which allows an early, precise diagnosis of degen-
erated leiomyomas.
Pain is the most frequent sign of uterine leiomyoma de-
generation. Pain is often severe and localized to the site of 
the leiomyoma. Severe pain associated with leiomyoma de-
generation often lasts for two to four weeks. In addition to 
pelvic pain, degeneration may cause a low-grade fever and 
a temporary elevation in the white blood cell count. In some 
cases, a degenerating uterine leiomyoma may cause menor-
rhagia, which can also result in a drop in hemoglobin levels. 
Symptoms of patients with degenerated leiomyomas in our 
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in patients referred for UFE was 5.1%. Patients presented 
with variable clinical symptoms with or without a history 
of pregnancy. MR imaging showed a high SI on T1WI and 
various SIs on T2WI without contrast enhancement. The 
majority of patients can be managed using conservative 
treatments; however, surgery or uterine artery embolization 
may be required in some patients. An understanding of the 
incidence and imaging features and clinical characteristics 
of the degeneration of leiomyoma is essential when consid-
ering UFE.  
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